Suchergebnisse - "Rendell, Marc S."

PubPharm (9)

1

Obesity and diabetes : the final frontier

enthalten in: Expert review of endocrinology & metabolism | 2023

von Rendell, M.

2

Sotagliflozin : a combined SGLT1/SGLT2 inhibitor to treat diabetes

enthalten in: Expert review of endocrinology & metabolism | 2018

von Rendell, M.

3

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes : A randomized, open-label clinical trial

enthalten in: Diabetes, obesity & metabolism | 2018

von Hollander, P. | Carofano, W. | Lam, R. | +8

4

Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment : a randomised clinical trial

enthalten in: Diabetologia | 2015

von Kothny, W. | Lukashevich, V. | Foley, J. | +2

5

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

enthalten in: The Journal of clinical investigation | 2015

von Rigby, M. | Harris, K. | Pinckney, A. | +24

6

DPP-4 inhibitors : focus on safety

enthalten in: Expert opinion on drug safety | 2015

von Tella, S. | Rendell, M.

7

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study) : 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

enthalten in: The lancet. Diabetes & endocrinology | 2013

von Rigby, M. | DiMeglio, L. | Rendell, M. | +121

CommentIn: Lancet Diabetes Endocrinol. 2013 Dec;1(4):261-3. - PMID 24622404

8

Targeting postprandial hyperglycemia

enthalten in: Metabolism: clinical and experimental | 2006

von Rendell, M. | Jovanovic, L.

9

Effect of cilostazol in patients with intermittent claudication : a randomized, double-blind, placebo-controlled study

enthalten in: Vascular and endovascular surgery | 2002

von Strandness, D. | Dalman, R. | Panian, S. | +4

1
[1]